|
US20020168718A1
(en)
*
|
1997-04-03 |
2002-11-14 |
California Institute Of Technology |
Enzyme-mediated modification of fibrin for tissue engineering
|
|
US7601685B2
(en)
*
|
1998-08-27 |
2009-10-13 |
Eidgenossische Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
EP2311895B1
(en)
|
1999-02-01 |
2017-04-12 |
Eidgenössische Technische Hochschule Zürich |
Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
|
|
US6958212B1
(en)
*
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
|
US7144991B2
(en)
|
1999-06-07 |
2006-12-05 |
Aletheon Pharmaceuticals, Inc. |
Streptavidin expressed gene fusions and methods of use thereof
|
|
AU5597500A
(en)
*
|
1999-06-07 |
2000-12-28 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7291673B2
(en)
*
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
|
WO2003052091A1
(en)
*
|
2001-12-18 |
2003-06-26 |
Eidgenossisch Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
US7247609B2
(en)
|
2001-12-18 |
2007-07-24 |
Universitat Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
EP1465989B1
(en)
*
|
2001-12-18 |
2008-02-20 |
Eidgenossisch Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
US8282912B2
(en)
*
|
2002-03-22 |
2012-10-09 |
Kuros Biosurgery, AG |
Compositions for tissue augmentation
|
|
US8603779B2
(en)
|
2004-12-01 |
2013-12-10 |
Syntaxin, Ltd. |
Non-cytotoxic protein conjugates
|
|
US8512984B2
(en)
|
2004-12-01 |
2013-08-20 |
Syntaxin, Ltd. |
Non-cytotoxic protein conjugates
|
|
US8399400B2
(en)
|
2004-12-01 |
2013-03-19 |
Syntaxin, Ltd. |
Fusion proteins
|
|
US8778634B2
(en)
|
2004-12-01 |
2014-07-15 |
Syntaxin, Ltd. |
Non-cytotoxic protein conjugates
|
|
GB0426394D0
(en)
*
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
AU2005318097A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Kuros Biosurgery Ag |
Michael-type addition reaction functionalised peg hydrogels with factor XIIIA incorporated biofactors
|
|
CA2592973A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Kuros Biosurgery Ag |
Supplemented matrices for the repair of bone fractures
|
|
WO2006073711A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Kuros Biosurgery Ag |
Use of a matrix comprising a contrast agent in soft tissues
|
|
US8575101B2
(en)
|
2005-01-06 |
2013-11-05 |
Kuros Biosurgery Ag |
Supplemented matrices for the repair of bone fractures
|
|
GB0610867D0
(en)
|
2006-06-01 |
2006-07-12 |
Syntaxin Ltd |
Treatment of pain
|
|
ES2733276T3
(es)
|
2007-04-13 |
2019-11-28 |
Kuros Biosurgery Ag |
Sellante polimérico para tejidos
|
|
WO2009083544A2
(en)
*
|
2007-12-28 |
2009-07-09 |
Kuros Biosurgery Ag |
Pdgf fusion proteins incorporated into fibrin foams
|
|
KR101431318B1
(ko)
|
2009-04-02 |
2014-08-20 |
로슈 글리카트 아게 |
전장 항체 및 단일쇄 ｆａｂ 단편을 포함하는 다중특이성 항체
|
|
CA2781519A1
(en)
|
2009-09-16 |
2011-03-24 |
Genentech, Inc. |
Coiled coil and/or tether containing protein complexes and uses thereof
|
|
TW201138821A
(en)
|
2010-03-26 |
2011-11-16 |
Roche Glycart Ag |
Bispecific antibodies
|
|
EP2609111B1
(en)
|
2010-08-24 |
2017-11-01 |
F. Hoffmann-La Roche AG |
Bispecific antibodies comprising a disulfide stabilized-fv fragment
|
|
JP5766296B2
(ja)
|
2010-12-23 |
2015-08-19 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
|
|
EP2678002A2
(en)
|
2011-02-25 |
2014-01-01 |
Medtronic, Inc. |
Therapy for kidney disease and/or heart failure
|
|
ES2882852T3
(es)
|
2011-03-16 |
2021-12-02 |
Kuros Biosurgery Ag |
Formulación farmacéutica para la utilización en la fusión espinal
|
|
US20130244937A1
(en)
|
2011-09-02 |
2013-09-19 |
Nile Therapeutics, Inc. |
Chimeric natriuretic peptide compositions and methods of preparation
|
|
EP2812357B1
(en)
|
2012-02-10 |
2020-11-04 |
F.Hoffmann-La Roche Ag |
Single-chain antibodies and other heteromultimers
|
|
KR20150030744A
(ko)
|
2012-06-27 |
2015-03-20 |
에프. 호프만-라 로슈 아게 |
표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도
|
|
RU2639287C2
(ru)
|
2012-06-27 |
2017-12-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
|
|
US20140056870A1
(en)
|
2012-08-27 |
2014-02-27 |
Allergan, Inc. |
Fusion proteins
|
|
JP6721590B2
(ja)
|
2014-12-03 |
2020-07-15 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
多重特異性抗体
|